Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2005 | 03-2005 | 12-2004 | 09-2004 | 06-2004 | |
| Sales | 2 | 0 | 2 | 5 | 508 |
| Gross Profit | 2 | 0 | 5 | 5 | 500 |
| Operating Expenses | 4,030 | 5,100 | 5,350 | 4,600 | 5,100 |
| Operating Income | -4,028 | -5,100 | -5,348 | -4,595 | -4,592 |
| Interest Expense | 60 | 60 | 70 | 50 | 50 |
| Other Income | -4,762 | 90 | 138 | 65 | 62 |
| Pre-tax Income | -8,850 | -5,070 | -5,280 | -4,580 | -4,580 |
| Net Income Continuous | -8,853 | -5,076 | -5,278 | -4,581 | -4,582 |
| Net Income | $-8,853 | $-5,076 | $-5,278 | $-4,581 | $-4,582 |
| EPS Basic Total Ops | -62.39 | -38.39 | -43.19 | -35.99 | -38.39 |
| EPS Basic Continuous Ops | -62.04 | -38.31 | -41.04 | -36.13 | -36.22 |
| EPS Diluted Total Ops | -62.39 | -38.39 | -43.19 | -35.99 | -38.39 |
| EPS Diluted Continuous Ops | -62.04 | -38.31 | -41.04 | -36.13 | -36.22 |
| EBITDA(a) | $-3,908 | $-4,900 | $-5,138 | $-4,385 | $-4,382 |